TCL Archive NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy October 26, 1984
TCL Archive Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin October 17, 2014